维普期刊资源整合服务平台（V6.5）

205篇 您的检索式：作者名="Vellenga"

选中清除导出查看参考文献查看引证文献引用追踪共11页首页上一页第1页下一页末页 /11 跳转

	题名	作者	年代	出处	被引量
1	Treatment strategies in acute myeloid leukemia显示文摘为尖锐 myeloid 白血病( AML )总结风险层化和当前的处理策略并且讨论可能在临床的 trials.Data 采购的未来被使用的新兴的新奇代理人的角色的目的在这篇文章的数据从 PubMed 数据库被收集,相关英语文章从 1991~2009 篇 .Study 选择文章出版了关于风险,层化和 AML 的治疗学的选择,以及白血病的干细胞的特征是 selected.Results AML 在 AML 致病和开发的理解的进展将产生可能更深改进标准 chemotherapy.Conclusion 的治疗结果的潜在的新奇代理人进 AML 的多重转变事件的卓见可以在基于单个病人设计小分子禁止者的联合帮助我们特征。	HAN Li-na ZHOU Jin Jan Jacob Schuringa Edo Vellenga	2011	Chinese Medical Journal2011，，9：	6
2	Ser727-dependent transcriptional activation by association of p300 with STAT3 upon IL-6 stimulation显示文摘	Schuringa J J Schepers H Vellenga E	2001	FEBS letters2001，495，1：	1
3	Peripheral blood stem cell transplantation as an alternative to autologous marrow transplantation in the treatment of acute myeloid leukemia?显示文摘	Vellenga E van Putten WL Boogaerts MA	1999	Bone Marrow Transplant1999，23，12：	1
4	Effects of IL-10 and IL-4 on LPS-induced transcription factors (AP-1,NF-IL6 and NF-kappa B) which are involved in IL-6 regulation显示文摘	Dokter WHA Koopmans SB Vellenga E	1996	Leukemia1996，10，8：	1
5	Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin显示文摘	De la Serna J Montesinos P Vellenga E	2008	Blood2008，111，7：	1
6	Sulfasalazine induced agranulocytosis treated with granulocyte-macrophage colony stimulating factor 显示文摘	Kuipers E J Vellenga E de Wolf JT	1992	J Rheumatol1992，19，4：	1
7	Tissue distribution of the death ligand TRAIL and its receptors显示文摘	Spierings DC De Vries EG Vellenga E	2004	Histochem Cytochem2004，52，6：	1
8	The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia显示文摘	G Klein E Vellenga M.W Fraaije W.A Kamps E.S.J.M. de Bont	2003	Critical Reviews in Oncology and Hematology2003，，：	1
9	Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin 显示文摘	De La Serna J Montesinos P Vellenga E	2008	Blood2008，111，7：	1
10	The influence of the membrane zeta potential on the critical flux for crossflow microfiltration of particle suspensions显示文摘	Huisman I H Vellenga E Gun Tr(a)g(a)rdh		0，，01：	1
11	Clinical significance of CD56 expression in patients with acute promyeloeytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens 显示文摘	Montesinos P Ray6n C Vellenga E	2011	Blood2011，117，6：	1
12	The influence of the membrane zeta potential on the critical flux for crossflow microfiltration of partical suspensions显示文摘	Huisman I H Vellenga E Tragardh G	1999	J Membr Sci1999，156，：	1
13	Using Logistics Alliances to Gain a Strategic Advantage in the Marketplace显示文摘	Gentry Vellenga	1996	Journal of Marketing Theory and Practice1996，，02：	1
14	Learning Pragmatics from ESL&EFL Textbooks:How likely?显示文摘	H	2004	Teaching English as a Second or Foreign Language2004，，2：	1
15	Differen- tiation syndrome in patients with acute promyelocytic leukemia treated with all - trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors 显示文摘	MONTESINOS P BERGUA J M VELLENGA E	2009	Blood2009，113，4：	1
16	Analysis of the efficacy and toxicity of bortezumib for treatment of relapsed or refractory multiple myeloma in community practice显示文摘	Wu K L Wieringen W Vellenga E	2005	Haematologica2005，90，7：	1
17	Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all - trans retinoic acid and idarubicin显示文摘	DE LA SERNA J MONTESINOS P VELLENGA E	2008	Blood2008，111，7：	1
18	Cytarabine do- se for acute myeloid leukemia显示文摘	Lowenberg B Pabst T Vellenga E	2011	N Engl J Med2011，364，11：	1
19	The influence of the membrane zeta potentially on the critical flux for crossflow microfiltration of particle suspensions显示文摘	Huisman I H Vellenga E Tragardh G	1999	Journal of Membrane Science1999，156，1：	1
20	Sequiential activation of Rac-1 ,SEK-1/MKK-4,and protein kinase Cdelta is required for interleukin-6-induced STAT3 Ser-727 phosphorylation and transactivation 显示文摘	Schuringa JJ Dekker LV Vellenga E	2001	J Biol Chem2001，276，27：	1

返回顶部每页显示：

共11页首页上一页第1页下一页末页 /11 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示